CEO Minami Maeda is running Phase 3 trials and targeting a 2028 FDA submission as photoimmunotherapy moves from Japanese clinics toward the world's largest market.

A policy rewrite opens the door, and Google's new Personal Intelligence tool is the gateway for your most sensitive data.

The marketplace is forcing sellers to prove their items are real, targeting AI-generated listings that buyers say they can't identify.

The deal raises a key question: should companies cover executives' personal tax bills?

Beijing's EV giants are shifting from exports to local assembly, spending billions to keep their European sales boom alive.

The crypto exchange is raising fresh capital to close the gap with larger U.S. rivals, betting a $1 billion valuation still holds weight.

Bhusri is shifting Workday to usage-based AI pricing, targeting the tens of millions customers spend on outsourcing.